位置:成果数据库 > 期刊 > 期刊详情页
Research and Development of New Chinese Materia Medica for Treatment of Refractory Hematopathy by Establishment and Application of Multiple Technique Platforms
  • 时间:0
  • 分类:R552[医药卫生—血液循环系统疾病;医药卫生—临床医学;医药卫生—内科学]
  • 作者机构:[1]Institute of Hematology, The First Affiliated Hospital of ZhejiangUniversity of Traditional Chinese Medicine, Hangzhou 310006
  • 相关基金:Supported by Australia-China Links Program sponsored by IDP Education Australia (No. 11-8), the National Natural Science Foundation of China (No. 30070933), the Natural Science Foundation of Zhejiang Province as the key project (No. DZ007), and State Administration of TCM of China (No. 972025).
作者: 高瑞兰[1]
中文摘要:

发现有效中国物质苜蓿是必要的一(CMM ) 通常为是的倔强的血液病的治疗使用抑制代理人经常表明的泼尼松,雄激素和免疫者差的功效和严肃的副作用。

英文摘要:

Research Objective and Overview It is necessary to find effective Chinese materia medica (CMM) for the treatment of refractory hematopathy as commonly used prednisone, androgen and immune suppression agents of tendemonstrate poor efficacy and serious side effects.

同期刊论文项目
同项目期刊论文